Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report

V. Perilli; Paola Aceto; A. Russo; B. Romano; Giuseppe Quero; Miceli D. Di; Sergio Alfieri; A. M. Berrito; Americo Cicchetti; L. Sollazzi

doi:10.1109/MeMeA.2018.8438724

Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report

V. Perilli
, Paola Aceto
, A. Russo
, B. Romano
, Giuseppe Quero
, Miceli D. Di
, Sergio Alfieri
, A. M. Berrito
, Americo Cicchetti
, L. Sollazzi

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Aim of this study was to evaluate if the use of a fluid-therapy protocol performed by a minimally-invasive hemodynamic device could improve outcome and reduce healthcare costs in patients undergoing pancreatic surgery.One-hundred-seventy-three patients undergoing pancreatic surgery were included in this before-and-after study. Patients underwent a goal-directed fluid-therapy (GDFT group) regimen by the Vigileo/FloTrac system following NICE (National Institute for Health and Care Excellence) protocol (GDFT, n=69 pts). The control group (CON group) consisted of 104 patients who underwent the same type of surgery in the previous 2 years. In CON group patients fluid-therapy was managed on the basis of conventional hemodynamic parameters. Exclusion criteria were age [removed]

Lingua originale	Inglese
pagine (da-a)	1-6
Numero di pagine	6
Rivista	MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings
Numero di pubblicazione	N/A
DOI	https://doi.org/10.1109/MeMeA.2018.8438724
Stato di pubblicazione	Pubblicato - 2018

All Science Journal Classification (ASJC) codes

Ingegneria Biomedica
Informatica della Salute
Strumentazione

Keywords

hemodynamic optimization

Accesso al documento

10.1109/MeMeA.2018.8438724

Altri file e collegamenti

Cita questo

Perilli, V., Aceto, P., Russo, A., Romano, B., Quero, G., Di, M. D., Alfieri, S., Berrito, A. M., Cicchetti, A., & Sollazzi, L. (2018). Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report. MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings, (N/A), 1-6. https://doi.org/10.1109/MeMeA.2018.8438724

@article{558455be49e440eaa9dd43a0c68d0039,

title = "Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report",

abstract = "Aim of this study was to evaluate if the use of a fluid-therapy protocol performed by a minimally-invasive hemodynamic device could improve outcome and reduce healthcare costs in patients undergoing pancreatic surgery.One-hundred-seventy-three patients undergoing pancreatic surgery were included in this before-and-after study. Patients underwent a goal-directed fluid-therapy (GDFT group) regimen by the Vigileo/FloTrac system following NICE (National Institute for Health and Care Excellence) protocol (GDFT, n=69 pts). The control group (CON group) consisted of 104 patients who underwent the same type of surgery in the previous 2 years. In CON group patients fluid-therapy was managed on the basis of conventional hemodynamic parameters. Exclusion criteria were age [removed]",

keywords = "hemodynamic optimization, hemodynamic optimization",

author = "V. Perilli and Paola Aceto and A. Russo and B. Romano and Giuseppe Quero and Di, \{Miceli D.\} and Sergio Alfieri and Berrito, \{A. M.\} and Americo Cicchetti and L. Sollazzi",

year = "2018",

doi = "10.1109/MeMeA.2018.8438724",

language = "English",

pages = "1--6",

journal = "MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings",

publisher = "Institute of Electrical and Electronics Engineers Inc",

number = "N/A",

}

Perilli, V, Aceto, P, Russo, A, Romano, B, Quero, G, Di, MD, Alfieri, S, Berrito, AM, Cicchetti, A & Sollazzi, L 2018, 'Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report', MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings, n. N/A, pagg. 1-6. https://doi.org/10.1109/MeMeA.2018.8438724

TY - JOUR

T1 - Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report

AU - Perilli, V.

AU - Aceto, Paola

AU - Russo, A.

AU - Romano, B.

AU - Quero, Giuseppe

AU - Di, Miceli D.

AU - Alfieri, Sergio

AU - Berrito, A. M.

AU - Cicchetti, Americo

AU - Sollazzi, L.

PY - 2018

Y1 - 2018

N2 - Aim of this study was to evaluate if the use of a fluid-therapy protocol performed by a minimally-invasive hemodynamic device could improve outcome and reduce healthcare costs in patients undergoing pancreatic surgery.One-hundred-seventy-three patients undergoing pancreatic surgery were included in this before-and-after study. Patients underwent a goal-directed fluid-therapy (GDFT group) regimen by the Vigileo/FloTrac system following NICE (National Institute for Health and Care Excellence) protocol (GDFT, n=69 pts). The control group (CON group) consisted of 104 patients who underwent the same type of surgery in the previous 2 years. In CON group patients fluid-therapy was managed on the basis of conventional hemodynamic parameters. Exclusion criteria were age [removed]

AB - Aim of this study was to evaluate if the use of a fluid-therapy protocol performed by a minimally-invasive hemodynamic device could improve outcome and reduce healthcare costs in patients undergoing pancreatic surgery.One-hundred-seventy-three patients undergoing pancreatic surgery were included in this before-and-after study. Patients underwent a goal-directed fluid-therapy (GDFT group) regimen by the Vigileo/FloTrac system following NICE (National Institute for Health and Care Excellence) protocol (GDFT, n=69 pts). The control group (CON group) consisted of 104 patients who underwent the same type of surgery in the previous 2 years. In CON group patients fluid-therapy was managed on the basis of conventional hemodynamic parameters. Exclusion criteria were age [removed]

KW - hemodynamic optimization

UR - https://publicatt.unicatt.it/handle/10807/248797

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85053108525&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053108525&origin=inward

U2 - 10.1109/MeMeA.2018.8438724

DO - 10.1109/MeMeA.2018.8438724

M3 - Article

SP - 1

EP - 6

JO - MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings

JF - MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings

IS - N/A

ER -

Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo